{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:03:46Z","timestamp":1789495426390,"version":"build-2803163510"},"reference-count":310,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41584-025-01327-5","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:37:26Z","timestamp":1765445846000},"page":"8-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Monogenic disorders of the TNF signalling pathway"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-3324","authenticated-orcid":false,"given":"Najoua","family":"Lalaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-576X","authenticated-orcid":false,"given":"Seth L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"1327_CR1","doi-asserted-by":"publisher","first-page":"1219907","DOI":"10.3389\/fimmu.2023.1219907","volume":"14","author":"H Steele","year":"2023","unstructured":"Steele, H. et al. TNF superfamily control of tissue remodeling and fibrosis. Front. Immunol. 14, 1219907 (2023).","journal-title":"Front. Immunol."},{"key":"1327_CR2","doi-asserted-by":"publisher","first-page":"1213448","DOI":"10.3389\/fimmu.2023.1213448","volume":"14","author":"NG Caldito","year":"2023","unstructured":"Caldito, N. G. Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders. Front. Immunol. 14, 1213448 (2023).","journal-title":"Front. Immunol."},{"key":"1327_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/0092-8674(93)90464-2","volume":"74","author":"LA Tartaglia","year":"1993","unstructured":"Tartaglia, L. A., Ayres, T. M., Wong, G. H. W. & Goeddel, D. V. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845\u2013853 (1993).","journal-title":"Cell"},{"key":"1327_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","volume":"81","author":"H Hsu","year":"1995","unstructured":"Hsu, H., Xiong, J. & Goeddel, D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-\u03baB activation. Cell 81, 495\u2013504 (1995).","journal-title":"Cell"},{"key":"1327_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80252-6","volume":"4","author":"H Hsu","year":"1996","unstructured":"Hsu, H., Huang, J., Shu, H.-B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387\u2013396 (1996).","journal-title":"Immunity"},{"key":"1327_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","volume":"84","author":"H Hsu","year":"1996","unstructured":"Hsu, H., Shu, H.-B., Pan, M.-G. & Goeddel, D. V. TRADD\u2013TRAF2 and TRADD\u2013FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299\u2013308 (1996).","journal-title":"Cell"},{"key":"1327_CR7","doi-asserted-by":"publisher","first-page":"35906","DOI":"10.1074\/jbc.M109.072256","volume":"284","author":"JE Vince","year":"2009","unstructured":"Vince, J. E. et al. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (TNF) to efficiently activate NF-\u03baB and to prevent TNF-induced apoptosis. J. Biol. Chem. 284, 35906\u201335915 (2009).","journal-title":"J. Biol. Chem."},{"key":"1327_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1074\/jbc.M509381200","volume":"281","author":"T Samuel","year":"2006","unstructured":"Samuel, T. et al. Distinct BIR Domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases*. J. Biol. Chem. 281, 1080\u20131090 (2006).","journal-title":"J. Biol. Chem."},{"key":"1327_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","volume":"30","author":"MJM Bertrand","year":"2008","unstructured":"Bertrand, M. J. M. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689\u2013700 (2008).","journal-title":"Mol. Cell"},{"key":"1327_CR10","doi-asserted-by":"publisher","first-page":"24295","DOI":"10.1074\/jbc.C800128200","volume":"283","author":"E Varfolomeev","year":"2008","unstructured":"Varfolomeev, E. et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor \u03b1 (TNF\u03b1)-induced NF-\u03baB activation. J. Biol. Chem. 283, 24295\u201324299 (2008).","journal-title":"J. Biol. Chem."},{"key":"1327_CR11","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/emboj.2010.300","volume":"29","author":"JN Dynek","year":"2010","unstructured":"Dynek, J. N. et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29, 4198\u20134209 (2010).","journal-title":"EMBO J."},{"key":"1327_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2009.10.013","volume":"36","author":"TL Haas","year":"2009","unstructured":"Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831\u2013844 (2009).","journal-title":"Mol. Cell"},{"key":"1327_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature09816","volume":"471","author":"B Gerlach","year":"2011","unstructured":"Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591\u2013596 (2011).","journal-title":"Nature"},{"key":"1327_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ncb1821","volume":"11","author":"F Tokunaga","year":"2009","unstructured":"Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-\u03baB activation. Nat. Cell Biol. 11, 123\u2013132 (2009).","journal-title":"Nat. Cell Biol."},{"key":"1327_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature09814","volume":"471","author":"F Ikeda","year":"2011","unstructured":"Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-\u03baB activity and apoptosis. Nature 471, 637\u2013641 (2011).","journal-title":"Nature"},{"key":"1327_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","volume":"15","author":"A Kanayama","year":"2004","unstructured":"Kanayama, A. et al. TAB2 and TAB3 Activate the NF-\u03baB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535\u2013548 (2004).","journal-title":"Mol. Cell"},{"key":"1327_CR17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41556-018-0229-6","volume":"20","author":"E Lafont","year":"2018","unstructured":"Lafont, E. et al. TBK1 and IKK\u03b5 prevent TNF-induced cell death by RIPK1 phosphorylation. Nat. Cell Biol. 20, 1389\u20131399 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1327_CR18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2009.03.007","volume":"136","author":"S Rahighi","year":"2009","unstructured":"Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO Is important for NF-\u03baB activation. Cell 136, 1098\u20131109 (2009).","journal-title":"Cell"},{"key":"1327_CR19","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.celrep.2015.11.009","volume":"13","author":"P Draber","year":"2015","unstructured":"Draber, P. et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13, 2258\u20132272 (2015).","journal-title":"Cell Rep."},{"key":"1327_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2014.03.018","volume":"54","author":"PR Elliott","year":"2014","unstructured":"Elliott, P. R. et al. Molecular basis and regulation of OTULIN-LUBAC interaction. Mol. Cell 54, 335\u2013348 (2014).","journal-title":"Mol. Cell"},{"key":"1327_CR21","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cell.2013.05.014","volume":"153","author":"K Keusekotten","year":"2013","unstructured":"Keusekotten, K. et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing met1-linked polyubiquitin. Cell 153, 1312\u20131326 (2013).","journal-title":"Cell"},{"key":"1327_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181\u2013190 (2003).","journal-title":"Cell"},{"key":"1327_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00406-w","volume":"8","author":"J Geng","year":"2017","unstructured":"Geng, J. et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat. Commun. 8, 359 (2017).","journal-title":"Nat. Commun."},{"key":"1327_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09690-0","volume":"10","author":"Y Dondelinger","year":"2019","unstructured":"Dondelinger, Y. et al. Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nat. Commun. 10, 1729 (2019).","journal-title":"Nat. Commun."},{"key":"1327_CR25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.cell.2018.07.041","volume":"174","author":"D Xu","year":"2018","unstructured":"Xu, D. et al. TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 174, 1477\u20131491.e19 (2018).","journal-title":"Cell"},{"key":"1327_CR26","doi-asserted-by":"publisher","first-page":"107547","DOI":"10.1016\/j.celrep.2020.107547","volume":"31","author":"W Wu","year":"2020","unstructured":"Wu, W. et al. The autophagy-initiating kinase ULK1 controls RIPK1-mediated cell death. Cell Rep. 31, 107547 (2020).","journal-title":"Cell Rep."},{"key":"1327_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34080-4","volume":"13","author":"H Tu","year":"2022","unstructured":"Tu, H., Xiong, W., Zhang, J., Zhao, X. & Lin, X. Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation. Nat. Commun. 13, 6603 (2022).","journal-title":"Nat. Commun."},{"key":"1327_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2015.07.032","volume":"60","author":"Y Dondelinger","year":"2015","unstructured":"Dondelinger, Y. et al. NF-\u03baB-independent role of IKK\u03b1\/IKK\u03b2 in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol. Cell 60, 63\u201376 (2015).","journal-title":"Mol. Cell"},{"key":"1327_CR29","doi-asserted-by":"publisher","first-page":"45162","DOI":"10.1074\/jbc.M206882200","volume":"277","author":"O Micheau","year":"2002","unstructured":"Micheau, O. et al. The long form of FLIP Is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277, 45162\u201345171 (2002).","journal-title":"J. Biol. Chem."},{"key":"1327_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst, A. et al. Catalytic activity of the caspase-8\u2013FLIPL complex inhibits RIPK3-dependent necrosis. Nature 471, 363\u2013367 (2011).","journal-title":"Nature"},{"key":"1327_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/BJ20101738","volume":"433","author":"C Pop","year":"2011","unstructured":"Pop, C. et al. FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem. J. 433, 447\u2013457 (2011).","journal-title":"Biochem. J."},{"key":"1327_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","volume":"577","author":"N Lalaoui","year":"2020","unstructured":"Lalaoui, N. et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature 577, 103\u2013108 (2020).","journal-title":"Nature"},{"key":"1327_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1126\/science.add6967","volume":"378","author":"J Huyghe","year":"2022","unstructured":"Huyghe, J. et al. ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway. Science 378, 1201\u20131207 (2022).","journal-title":"Science"},{"key":"1327_CR34","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/cancers14112603","volume":"14","author":"J Medler","year":"2022","unstructured":"Medler, J., Kucka, K. & Wajant, H. Tumor necrosis factor receptor 2 (TNFR2): an emerging target in cancer therapy. Cancers 14, 2603 (2022).","journal-title":"Cancers"},{"key":"1327_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0092-8674(94)90532-0","volume":"78","author":"M Rothe","year":"1994","unstructured":"Rothe, M., Wong, S. C., Henzel, W. J. & Goeddel, D. V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681\u2013692 (1994).","journal-title":"Cell"},{"key":"1327_CR36","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/0092-8674(95)90149-3","volume":"83","author":"M Rothe","year":"1995","unstructured":"Rothe, M., Pan, M.-G., Henzel, W. J., Ayres, T. M. & Goeddel, D. V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243\u20131252 (1995).","journal-title":"Cell"},{"key":"1327_CR37","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.4049\/jimmunol.158.5.2398","volume":"158","author":"T Weiss","year":"1997","unstructured":"Weiss, T. et al. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J. Immunol. 158, 2398\u20132404 (1997).","journal-title":"J. Immunol."},{"key":"1327_CR38","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/sj.emboj.7600649","volume":"24","author":"C Wu","year":"2005","unstructured":"Wu, C. et al. TNF-\u03b1 induced c-IAP1\/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J. 24, 1886\u20131898 (2005).","journal-title":"EMBO J."},{"key":"1327_CR39","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/1521-4141(200002)30:2<652::AID-IMMU652>3.0.CO;2-L","volume":"30","author":"FK Chan","year":"2000","unstructured":"Chan, F. K. & Lenardo, M. J. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur. J. Immunol. 30, 652\u2013660 (2000).","journal-title":"Eur. J. Immunol."},{"key":"1327_CR40","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1242\/jcs.115.13.2757","volume":"115","author":"M Fotin-Mleczek","year":"2002","unstructured":"Fotin-Mleczek, M. et al. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J. Cell Sci. 115, 2757\u20132770 (2002).","journal-title":"J. Cell Sci."},{"key":"1327_CR41","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/ni.1678","volume":"9","author":"S Vallabhapurapu","year":"2008","unstructured":"Vallabhapurapu, S. et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-\u03baB signaling. Nat. Immunol. 9, 1364\u20131370 (2008).","journal-title":"Nat. Immunol."},{"key":"1327_CR42","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/ni.1676","volume":"9","author":"BJ Zarnegar","year":"2008","unstructured":"Zarnegar, B. J. et al. Noncanonical NF-\u03baB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371\u20131378 (2008).","journal-title":"Nat. Immunol."},{"key":"1327_CR43","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.celrep.2017.06.073","volume":"20","author":"KE Lawlor","year":"2017","unstructured":"Lawlor, K. E. et al. XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1\u03b2 activation and cell death as a consequence of TLR-MyD88-induced cIAP1-TRAF2 degradation. Cell Rep. 20, 668\u2013682 (2017).","journal-title":"Cell Rep."},{"key":"1327_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1938-x","volume":"10","author":"J Knop","year":"2019","unstructured":"Knop, J. et al. TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell Death Dis. 10, 700 (2019).","journal-title":"Cell Death Dis."},{"key":"1327_CR45","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","volume":"7","author":"M Yabal","year":"2014","unstructured":"Yabal, M. et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 7, 1796\u20131808 (2014).","journal-title":"Cell Rep."},{"key":"1327_CR46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.molcel.2017.05.003","volume":"66","author":"I Jaco","year":"2017","unstructured":"Jaco, I. et al. MK2 Phosphorylates RIPK1 to Prevent TNF-induced cell death. Mol. Cell 66, 698\u2013710.e5 (2017).","journal-title":"Mol. Cell"},{"key":"1327_CR47","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ncb3614","volume":"19","author":"MB Menon","year":"2017","unstructured":"Menon, M. B. et al. p38MAPK\/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. Nat. Cell Biol. 19, 1248\u20131259 (2017).","journal-title":"Nat. Cell Biol."},{"key":"1327_CR48","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/ncb3608","volume":"19","author":"Y Dondelinger","year":"2017","unstructured":"Dondelinger, Y. et al. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat. Cell Biol. 19, 1237\u20131247 (2017).","journal-title":"Nat. Cell Biol."},{"key":"1327_CR49","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.celrep.2018.03.054","volume":"23","author":"R Feltham","year":"2018","unstructured":"Feltham, R. et al. Mind bomb regulates cell death during TNF signaling by suppressing RIPK1\u2019s cytotoxic potential. Cell Rep. 23, 470\u2013484 (2018).","journal-title":"Cell Rep."},{"key":"1327_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh2332","volume":"8","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death. Sci. Adv. 8, eabh2332 (2022).","journal-title":"Sci. Adv."},{"key":"1327_CR51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bcp.2018.01.039","volume":"153","author":"A Borghi","year":"2018","unstructured":"Borghi, A. et al. The E3 ubiquitin ligases HOIP and cIAP1 are recruited to the TNFR2 signaling complex and mediate TNFR2-induced canonical NF-\u03baB signaling. Biochem. Pharmacol. 153, 292\u2013298 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"1327_CR52","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.molcel.2018.01.027","volume":"69","author":"A Annibaldi","year":"2018","unstructured":"Annibaldi, A. et al. Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2. Mol. Cell 69, 566\u2013580.e5 (2018).","journal-title":"Mol. Cell"},{"key":"1327_CR53","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/emboj.2012.18","volume":"31","author":"M Moulin","year":"2012","unstructured":"Moulin, M. et al. IAPs limit activation of RIP kinases by TNF receptor 1 during development: IAPs prevent lethal activation of RIPKs by TNF. EMBO J. 31, 1679\u20131691 (2012).","journal-title":"EMBO J."},{"key":"1327_CR54","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-018-0064-8","volume":"557","author":"N Peltzer","year":"2018","unstructured":"Peltzer, N. et al. LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. Nature 557, 112\u2013117 (2018).","journal-title":"Nature"},{"key":"1327_CR55","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"Y Cho","year":"2009","unstructured":"Cho, Y. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112\u20131123 (2009).","journal-title":"Cell"},{"key":"1327_CR56","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao, J. et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc. Natl Acad. Sci. USA 109, 5322\u20135327 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213\u2013227 (2012).","journal-title":"Cell"},{"key":"1327_CR58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443\u2013453 (2013).","journal-title":"Immunity"},{"key":"1327_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99\u2013103 (2017).","journal-title":"Nature"},{"key":"1327_CR60","doi-asserted-by":"publisher","first-page":"14128","DOI":"10.1038\/ncomms14128","volume":"8","author":"C Rogers","year":"2017","unstructured":"Rogers, C. et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death. Nat. Commun. 8, 14128 (2017).","journal-title":"Nat. Commun."},{"key":"1327_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","volume":"25","author":"RC Coll","year":"2025","unstructured":"Coll, R. C. & Schroder, K. Inflammasome components as new therapeutic targets in inflammatory disease. Nat. Rev. Immunol. 25, 22\u201341 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"1327_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc3465","volume":"6","author":"B Demarco","year":"2020","unstructured":"Demarco, B. et al. Caspase-8\u2013dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-induced lethality. Sci. Adv. 6, eabc3465 (2020).","journal-title":"Sci. Adv."},{"key":"1327_CR63","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.aau2818","volume":"362","author":"P Orning","year":"2018","unstructured":"Orning, P. et al. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science 362, 1064\u20131069 (2018).","journal-title":"Science"},{"key":"1327_CR64","doi-asserted-by":"publisher","first-page":"E10888","DOI":"10.1073\/pnas.1809548115","volume":"115","author":"J Sarhan","year":"2018","unstructured":"Sarhan, J. et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc. Natl Acad. Sci. USA 115, E10888\u2013E10897 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR65","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-024-01281-x","volume":"31","author":"HT Tran","year":"2924","unstructured":"Tran, H. T. et al. RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation. Cell Death Differ. 31, 662\u2013671 (2924).","journal-title":"Cell Death Differ."},{"key":"1327_CR66","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-019-1752-8","volume":"575","author":"K Newton","year":"2019","unstructured":"Newton, K. et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature 575, 679\u2013682 (2019).","journal-title":"Nature"},{"key":"1327_CR67","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch, M. et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575, 683\u2013687 (2019).","journal-title":"Nature"},{"key":"1327_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott, M. F. et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133\u2013144 (1999).","journal-title":"Cell"},{"key":"1327_CR69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1086\/321976","volume":"69","author":"I Aksentijevich","year":"2001","unstructured":"Aksentijevich, I. et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am. J. Hum. Genet. 69, 301\u2013314 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"1327_CR70","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1086\/301886","volume":"62","author":"MF McDermott","year":"1998","unstructured":"McDermott, M. F. et al. Linkage of familial Hibernian fever to chromosome 12p13. Am. J. Hum. Genet. 62, 1446\u20131451 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"1327_CR71","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/ard.2005.048611","volume":"65","author":"N Ravet","year":"2006","unstructured":"Ravet, N. et al. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann. Rheum. Dis. 65, 1158\u20131162 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR72","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/ard.2007.079376","volume":"67","author":"S Stojanov","year":"2008","unstructured":"Stojanov, S. et al. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A\/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann. Rheum. Dis. 67, 1292\u20131298 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR73","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","volume":"73","author":"HJ Lachmann","year":"2014","unstructured":"Lachmann, H. J. et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry. Ann. Rheum. Dis. 73, 2160\u20132167 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR74","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1136\/ard.2007.078667","volume":"67","author":"SM Churchman","year":"2008","unstructured":"Churchman, S. M. et al. A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-\u03baB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS). Ann. Rheum. Dis. 67, 1589 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR75","first-page":"469","volume":"51","author":"LM Williamson","year":"1982","unstructured":"Williamson, L. M. et al. Familial Hibernian fever. Q. J. Med. 51, 469\u2013480 (1982).","journal-title":"Q. J. Med."},{"key":"1327_CR76","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1002\/j.1460-2075.1990.tb07526.x","volume":"9","author":"Y Nophar","year":"1990","unstructured":"Nophar, Y. et al. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9, 3269\u20133278 (1990).","journal-title":"EMBO J."},{"key":"1327_CR77","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","volume":"73","author":"DW Banner","year":"1993","unstructured":"Banner, D. W. et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF\u03b2 complex: implications for TNF receptor activation. Cell 73, 431\u2013445 (1993).","journal-title":"Cell"},{"key":"1327_CR78","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","volume":"288","author":"FK-M Chan","year":"2000","unstructured":"Chan, F. K.-M. et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351\u20132354 (2000).","journal-title":"Science"},{"key":"1327_CR79","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1084\/jem.175.2.323","volume":"175","author":"D Aderka","year":"1992","unstructured":"Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C. & Wallach, D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175, 323\u2013329 (1992).","journal-title":"J. Exp. Med."},{"key":"1327_CR80","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/art.21964","volume":"54","author":"SL Rebelo","year":"2006","unstructured":"Rebelo, S. L. et al. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum. 54, 2674\u20132687 (2006).","journal-title":"Arthritis Rheum."},{"key":"1327_CR81","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/art.20380","volume":"50","author":"ML Huggins","year":"2004","unstructured":"Huggins, M. L. et al. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum. 50, 2651\u20132659 (2004).","journal-title":"Arthritis Rheum."},{"key":"1327_CR82","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/art.11215","volume":"48","author":"E Aganna","year":"2003","unstructured":"Aganna, E. et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 48, 2632\u20132644 (2003).","journal-title":"Arthritis Rheum."},{"key":"1327_CR83","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1002\/art.21268","volume":"52","author":"N Yousaf","year":"2005","unstructured":"Yousaf, N. et al. Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-\u03baB activation. Arthritis Rheum. 52, 2906\u20132916 (2005).","journal-title":"Arthritis Rheum."},{"key":"1327_CR84","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/art.23123","volume":"58","author":"B Nedjai","year":"2008","unstructured":"Nedjai, B. et al. Abnormal tumor necrosis factor receptor I cell surface expression and NF-\u03baB activation in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 58, 273\u2013283 (2008).","journal-title":"Arthritis Rheum."},{"key":"1327_CR85","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/art.21657","volume":"54","author":"A D\u2019Osualdo","year":"2006","unstructured":"D\u2019Osualdo, A. et al. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum. 54, 998\u20131008 (2006).","journal-title":"Arthritis Rheum."},{"key":"1327_CR86","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/art.24294","volume":"60","author":"B Nedjai","year":"2009","unstructured":"Nedjai, B. et al. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 60, 619\u2013625 (2009).","journal-title":"Arthritis Rheum."},{"key":"1327_CR87","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/eji.201344328","volume":"44","author":"OH Negm","year":"2014","unstructured":"Negm, O. H. et al. A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS). Eur. J. Immunol. 44, 2096\u20132110 (2014).","journal-title":"Eur. J. Immunol."},{"key":"1327_CR88","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1182\/blood-2005-11-006783","volume":"108","author":"AA Lobito","year":"2006","unstructured":"Lobito, A. A. et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108, 1320\u20131327 (2006).","journal-title":"Blood"},{"key":"1327_CR89","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1016\/j.febslet.2005.08.037","volume":"579","author":"S Siebert","year":"2005","unstructured":"Siebert, S., Fielding, C. A., Williams, B. D. & Brennan, P. Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-\u03baB activation due to decreased surface expression. FEBS Lett. 579, 5193\u20135198 (2005).","journal-title":"FEBS Lett."},{"key":"1327_CR90","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.20102049","volume":"208","author":"AC Bulua","year":"2011","unstructured":"Bulua, A. C. et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med. 208, 519\u2013533 (2011).","journal-title":"J. Exp. Med."},{"key":"1327_CR91","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1136\/annrheumdis-2011-201197","volume":"71","author":"LJ Dickie","year":"2012","unstructured":"Dickie, L. J. et al. Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann. Rheum. Dis. 71, 2035 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR92","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.1073\/pnas.0914118107","volume":"107","author":"A Simon","year":"2010","unstructured":"Simon, A. et al. Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc. Natl Acad. Sci. 107, 9801\u20139806 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR93","doi-asserted-by":"publisher","first-page":"926175","DOI":"10.3389\/fimmu.2022.926175","volume":"13","author":"T Akagi","year":"2022","unstructured":"Akagi, T. et al. TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNF\u03b1 via reduced cell surface expression of TNFR1. Front. Immunol. 13, 926175 (2022).","journal-title":"Front. Immunol."},{"key":"1327_CR94","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N Haar","year":"2013","unstructured":"Haar, N. et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann. Rheum. Dis. 72, 678\u2013685 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR95","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.clim.2009.01.002","volume":"131","author":"Z Kaymakcalan","year":"2009","unstructured":"Kaymakcalan, Z. et al. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin. Immunol. 131, 308\u2013316 (2009).","journal-title":"Clin. Immunol."},{"key":"1327_CR96","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","volume":"36","author":"DE Furst","year":"2006","unstructured":"Furst, D. E., Wallis, R., Broder, M. & Beenhouwer, D. O. Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin. Arthritis Rheum. 36, 159\u2013167 (2006).","journal-title":"Semin. Arthritis Rheum."},{"key":"1327_CR97","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.amjmed.2004.02.039","volume":"117","author":"A Simon","year":"2004","unstructured":"Simon, A. et al. Beneficial response to interleukin 1 receptor antagonist in traps. Am. J. Med. 117, 208\u2013210 (2004).","journal-title":"Am. J. Med."},{"key":"1327_CR98","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10067-017-3688-4","volume":"36","author":"S Gentileschi","year":"2017","unstructured":"Gentileschi, S. et al. Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature. Clin. Rheumatol. 36, 1687\u20131690 (2017).","journal-title":"Clin. Rheumatol."},{"key":"1327_CR99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcdb.2020.08.007","volume":"109","author":"L Liu","year":"2021","unstructured":"Liu, L. & Lalaoui, N. 25 years of research put RIPK1 in the clinic. Semin. Cell Developmental Biol. 109, 86\u201395 (2021).","journal-title":"Semin. Cell Developmental Biol."},{"key":"1327_CR100","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","volume":"577","author":"P Tao","year":"2020","unstructured":"Tao, P. et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature 577, 109\u2013114 (2020).","journal-title":"Nature"},{"key":"1327_CR101","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10875-022-01298-2","volume":"42","author":"AJTI Reula","year":"2022","unstructured":"Reula, A. J. T. I. et al. Characterization of novel pathogenic variants leading to caspase-8 cleavage-resistant RIPK1-induced autoinflammatory syndrome. J. Clin. Immunol. 42, 1421\u20131432 (2022).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR102","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-019-1548-x","volume":"574","author":"K Newton","year":"2019","unstructured":"Newton, K. et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature 574, 428\u2013431 (2019).","journal-title":"Nature"},{"key":"1327_CR103","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1128\/MCB.00692-15","volume":"35","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. RIP1 cleavage in the kinase domain regulates TRAIL-induced NF-\u03baB activation and lymphoma survival. Mol. Cell Biol. 35, 3324\u20133338 (2015).","journal-title":"Mol. Cell Biol."},{"key":"1327_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1490-8","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Dowling, J. P. & Zhang, J. RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development. Cell Death Dis. 10, 245 (2019).","journal-title":"Cell Death Dis."},{"key":"1327_CR105","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard, J. A. et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175\u20131188 (2014).","journal-title":"Cell"},{"key":"1327_CR106","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2014.04.018","volume":"157","author":"CP Dillon","year":"2014","unstructured":"Dillon, C. P. et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189\u20131202 (2014).","journal-title":"Cell"},{"key":"1327_CR107","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1073\/pnas.1401857111","volume":"111","author":"WJ Kaiser","year":"2014","unstructured":"Kaiser, W. J. et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc. Natl Acad. Sci. 111, 7753\u20137758 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR108","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fcell.2015.00012","volume":"3","author":"JP Dowling","year":"2015","unstructured":"Dowling, J. P., Nair, A. & Zhang, J. A novel function of RIP1 in postnatal development and immune homeostasis by protecting against RIP3-dependent necroptosis and FADD-mediated apoptosis. Front. Cell Dev. Biol. 3, 12 (2015).","journal-title":"Front. Cell Dev. Biol."},{"key":"1327_CR109","doi-asserted-by":"publisher","unstructured":"Zhou, Q. et al. RIPK1 biallelic activating variants lead to autoinflammatory disease driven by T cell death. Preprint at\u00a0medRxiv https:\/\/doi.org\/10.1101\/2024.03.28.24304774 (2024).","DOI":"10.1101\/2024.03.28.24304774"},{"key":"1327_CR110","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","volume":"22","author":"C-K Ea","year":"2006","unstructured":"Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G. & Chen, Z. J. Activation of IKK by TNF\u03b1 requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245\u2013257 (2006).","journal-title":"Mol. Cell"},{"key":"1327_CR111","doi-asserted-by":"publisher","first-page":"13636","DOI":"10.1074\/jbc.M600620200","volume":"281","author":"H Li","year":"2006","unstructured":"Li, H., Kobayashi, M., Blonska, M., You, Y. & Lin, X. Ubiquitination of RIP Is required for tumor necrosis factor \u03b1-induced NF-\u03baB activation. J. Biol. Chem. 281, 13636\u201313643 (2006).","journal-title":"J. Biol. Chem."},{"key":"1327_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12033-8","volume":"10","author":"Y Tang","year":"2019","unstructured":"Tang, Y. et al. K63-linked ubiquitination regulates RIPK1 kinase activity to prevent cell death during embryogenesis and inflammation. Nat. Commun. 10, 4157 (2019).","journal-title":"Nat. Commun."},{"key":"1327_CR113","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.it.2021.05.003","volume":"42","author":"L Verboom","year":"2021","unstructured":"Verboom, L., Hoste, E. & Loo, G. van. OTULIN in NF-\u03baB signaling, cell death, and disease. Trends Immunol. 42, 590\u2013603 (2021).","journal-title":"Trends Immunol."},{"key":"1327_CR114","doi-asserted-by":"publisher","first-page":"EMMM201809324","DOI":"10.15252\/emmm.201809324","volume":"11","author":"RB Damgaard","year":"2019","unstructured":"Damgaard, R. B. et al. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol. Med. 11, EMMM201809324 (2019).","journal-title":"EMBO Mol. Med."},{"key":"1327_CR115","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2016.07.019","volume":"166","author":"RB Damgaard","year":"2016","unstructured":"Damgaard, R. B. et al. The deubiquitinase OTULIN Is an essential negative regulator of inflammation and autoimmunity. Cell 166, 1215\u20131230.e20 (2016).","journal-title":"Cell"},{"key":"1327_CR116","doi-asserted-by":"publisher","first-page":"10127","DOI":"10.1073\/pnas.1612594113","volume":"113","author":"Q Zhou","year":"2016","unstructured":"Zhou, Q. et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc. Natl Acad. Sci. 113, 10127\u201310132 (2016).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6794","volume":"7","author":"P Tao","year":"2021","unstructured":"Tao, P. et al. Deubiquitination of proteasome subunits by OTULIN regulates type I IFN production. Sci. Adv. 7, eabi6794 (2021).","journal-title":"Sci. Adv."},{"key":"1327_CR118","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10875-019-00599-3","volume":"39","author":"M Nabavi","year":"2019","unstructured":"Nabavi, M. et al. Auto-inflammation in a patient with a novel Homozygous OTULIN Mutation. J. Clin. Immunol. 39, 138\u2013141 (2019).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR119","doi-asserted-by":"publisher","first-page":"EMMM202114901","DOI":"10.15252\/emmm.202114901","volume":"14","author":"J Zinngrebe","year":"2022","unstructured":"Zinngrebe, J. et al. Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS. EMBO Mol. Med. 14, EMMM202114901 (2022).","journal-title":"EMBO Mol. Med."},{"key":"1327_CR120","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20222171","volume":"221","author":"S Davidson","year":"2024","unstructured":"Davidson, S. et al. Dominant negative OTULIN-related autoinflammatory syndrome. J. Exp. Med. 221, e20222171 (2024).","journal-title":"J. Exp. Med."},{"key":"1327_CR121","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231941","volume":"221","author":"Y Takeda","year":"2024","unstructured":"Takeda, Y. et al. A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome. J. Exp. Med. 221, e20231941 (2024).","journal-title":"J. Exp. Med."},{"key":"1327_CR122","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf4404","volume":"8","author":"MG Doglio","year":"2023","unstructured":"Doglio, M. G. et al. Myeloid OTULIN deficiency couples RIPK3-dependent cell death to Nlrp3 inflammasome activation and IL-1\u03b2 secretion. Sci. Immunol. 8, eadf4404 (2023).","journal-title":"Sci. Immunol."},{"key":"1327_CR123","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-018-0256-2","volume":"559","author":"K Heger","year":"2018","unstructured":"Heger, K. et al. OTULIN limits cell death and inflammation by deubiquitinating LUBAC. Nature 559, 120\u2013124 (2018).","journal-title":"Nature"},{"key":"1327_CR124","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature12296","volume":"498","author":"E Rivkin","year":"2013","unstructured":"Rivkin, E. et al. The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 498, 318\u2013324 (2013).","journal-title":"Nature"},{"key":"1327_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25944-2","volume":"12","author":"E Hoste","year":"2021","unstructured":"Hoste, E. et al. OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity. Nat. Commun. 12, 5913 (2021).","journal-title":"Nat. Commun."},{"key":"1327_CR126","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm6380","volume":"376","author":"AN Spaan","year":"2022","unstructured":"Spaan, A. N. et al. Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal \u03b1-toxin. Science 376, eabm6380 (2022).","journal-title":"Science"},{"key":"1327_CR127","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10875-023-01630-4","volume":"44","author":"RJW Arts","year":"2024","unstructured":"Arts, R. J. W. et al. OTULIN haploinsufficiency-related fasciitis and skin necrosis treated by TNF inhibition. J. Clin. Immunol. 44, 10 (2024).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR128","doi-asserted-by":"publisher","first-page":"983686","DOI":"10.3389\/fimmu.2024.983686","volume":"15","author":"F Staels","year":"2024","unstructured":"Staels, F. et al. OTULIN haploinsufficiency predisposes to environmentally directed inflammation. Front. Immunol. 15, 983686 (2024).","journal-title":"Front. Immunol."},{"key":"1327_CR129","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1016\/j.cell.2021.07.026","volume":"184","author":"J Taft","year":"2021","unstructured":"Taft, J. et al. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. Cell 184, 4447\u20134463.e20 (2021).","journal-title":"Cell"},{"key":"1327_CR130","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20161524","volume":"214","author":"Y Xiao","year":"2017","unstructured":"Xiao, Y. et al. The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J. Exp. Med. 214, 1493\u20131507 (2017).","journal-title":"J. Exp. Med."},{"key":"1327_CR131","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1189\/jlb.0210071","volume":"88","author":"E Marchlik","year":"2010","unstructured":"Marchlik, E. et al. Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality. J. Leukoc. Biol. 88, 1171\u20131180 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"1327_CR132","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1093\/emboj\/19.18.4976","volume":"19","author":"M Bonnard","year":"2000","unstructured":"Bonnard, M. et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-\u03baB-dependent gene transcription. EMBO J. 19, 4976\u20134985 (2000).","journal-title":"EMBO J."},{"key":"1327_CR133","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1084\/jem.20040520","volume":"199","author":"H Hemmi","year":"2004","unstructured":"Hemmi, H. et al. The roles of two I\u03baB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199, 1641\u20131650 (2004).","journal-title":"J. Exp. Med."},{"key":"1327_CR134","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1084\/jem.20040528","volume":"199","author":"AK Perry","year":"2004","unstructured":"Perry, A. K., Chow, E. K., Goodnough, J. B., Yeh, W.-C. & Cheng, G. Differential requirement for TANK-binding Kinase-1 in type I interferon responses to Toll-like receptor activation and viral infection. J. Exp. Med. 199, 1651\u20131658 (2004).","journal-title":"J. Exp. Med."},{"key":"1327_CR135","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.4049\/jimmunol.177.9.5785","volume":"177","author":"K Matsui","year":"2006","unstructured":"Matsui, K. et al. Cutting edge: role of TANK-binding kinase 1 and inducible I\u03baB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 177, 5785\u20135789 (2006).","journal-title":"J. Immunol."},{"key":"1327_CR136","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1073\/pnas.1813582116","volume":"116","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 116, 970\u2013975 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR137","doi-asserted-by":"publisher","first-page":"1041315","DOI":"10.3389\/fimmu.2022.1041315","volume":"13","author":"M Sultan","year":"2022","unstructured":"Sultan, M. et al. RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features. Front. Immunol. 13, 1041315 (2022).","journal-title":"Front. Immunol."},{"key":"1327_CR138","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.aar2641","volume":"361","author":"D Cuchet-Louren\u00e7o","year":"2018","unstructured":"Cuchet-Louren\u00e7o, D. et al. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science 361, 810\u2013813 (2018).","journal-title":"Science"},{"key":"1327_CR139","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s10038-019-0631-3","volume":"64","author":"Y Uchiyama","year":"2019","unstructured":"Uchiyama, Y. et al. Primary immunodeficiency with chronic enteropathy and developmental delay in a boy arising from a novel homozygous RIPK1 variant. J. Hum. Genet. 64, 955\u2013960 (2019).","journal-title":"J. Hum. Genet."},{"key":"1327_CR140","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10875-024-01707-8","volume":"44","author":"CT K\u0131rsa\u00e7l\u0131o\u011flu","year":"2024","unstructured":"K\u0131rsa\u00e7l\u0131o\u011flu, C. T. et al. Very-early-onset Inflammatory bowel disease in an infant with a partial RIPK1 deletion. J. Clin. Immunol. 44, 108 (2024).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR141","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10875-024-01850-2","volume":"45","author":"RB Walsh","year":"2025","unstructured":"Walsh, R. B. et al. Outcomes of hematopoietic stem cell transplantation in 5 patients with autosomal recessive RIPK1-deficiency. J. Clin. Immunol. 45, 65 (2025).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR142","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.gendis.2019.10.008","volume":"7","author":"L Lin","year":"2020","unstructured":"Lin, L. et al. Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation. Genes. Dis. 7, 122\u2013127 (2020).","journal-title":"Genes. Dis."},{"key":"1327_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7282","volume":"6","author":"KE Lawlor","year":"2015","unstructured":"Lawlor, K. E. et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun. 6, 6282 (2015).","journal-title":"Nat. Commun."},{"key":"1327_CR144","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature13706","volume":"513","author":"N Takahashi","year":"2014","unstructured":"Takahashi, N. et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513, 95\u201399 (2014).","journal-title":"Nature"},{"key":"1327_CR145","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature13608","volume":"513","author":"M Dannappel","year":"2014","unstructured":"Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90\u201394 (2014).","journal-title":"Nature"},{"key":"1327_CR146","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1074-7613(00)80535-X","volume":"8","author":"MA Kelliher","year":"1998","unstructured":"Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-\u03baB signal. Immunity 8, 297\u2013303 (1998).","journal-title":"Immunity"},{"key":"1327_CR147","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature01063","volume":"419","author":"HJ Chun","year":"2002","unstructured":"Chun, H. J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395\u2013399 (2002).","journal-title":"Nature"},{"key":"1327_CR148","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s10875-015-0150-8","volume":"35","author":"J Niemela","year":"2015","unstructured":"Niemela, J. et al. Caspase-8 deficiency presenting as late-onset multi-organ lymphocytic infiltration with granulomas in two adult siblings. J. Clin. Immunol. 35, 348\u2013355 (2015).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR149","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/j.gastro.2018.09.041","volume":"156","author":"AS Lehle","year":"2019","unstructured":"Lehle, A. S. et al. Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency. Gastroenterology 156, 275\u2013278 (2019).","journal-title":"Gastroenterology"},{"key":"1327_CR150","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13223-023-00778-3","volume":"19","author":"N Bazgir","year":"2023","unstructured":"Bazgir, N. et al. A rare immunological disease, caspase 8 deficiency: case report and literature review. Allergy, Asthma Clin. Immunol. 19, 29 (2023).","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"1327_CR151","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.3324\/haematol.2018.201673","volume":"104","author":"V Kanderova","year":"2019","unstructured":"Kanderova, V. et al. Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in caspase 8. Haematologica 104, e32\u2013e34 (2019).","journal-title":"Haematologica"},{"key":"1327_CR152","first-page":"937","volume":"14","author":"T Grzela","year":"2004","unstructured":"Grzela, T. et al. Impaired apoptosis of lymphocytes derived from patient with decreased expression of caspase-8 results in ALPS-like phenotype. Int. J. Mol. Med. 14, 937\u2013942 (2004).","journal-title":"Int. J. Mol. Med."},{"key":"1327_CR153","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1073\/pnas.1403477111","volume":"111","author":"D Weng","year":"2014","unstructured":"Weng, D. et al. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. Proc. Natl Acad. Sci. 111, 7391\u20137396 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8515","volume":"6","author":"S Kang","year":"2015","unstructured":"Kang, S. et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun. 6, 7515 (2015).","journal-title":"Nat. Commun."},{"key":"1327_CR155","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.immuni.2018.06.011","volume":"49","author":"P Mandal","year":"2018","unstructured":"Mandal, P. et al. Caspase-8 collaborates with caspase-11 to drive tissue damage and execution of endotoxic shock. Immunity 49, 42\u201355.e6 (2018).","journal-title":"Immunity"},{"key":"1327_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005910","volume":"12","author":"NH Philip","year":"2016","unstructured":"Philip, N. H. et al. Activity of uncleaved caspase-8 controls anti-bacterial immune defense and TLR-induced Cytokine production independent of cell death. PLoS Pathog. 12, e1005910 (2016).","journal-title":"PLoS Pathog."},{"key":"1327_CR157","doi-asserted-by":"publisher","first-page":"11926","DOI":"10.1073\/pnas.1820529116","volume":"116","author":"AA DeLaney","year":"2019","unstructured":"DeLaney, A. A. et al. Caspase-8 promotes c-Rel\u2013dependent inflammatory cytokine expression and resistance against Toxoplasma gondii. Proc. Natl Acad. Sci. 116, 11926\u201311935 (2019).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR158","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molcel.2017.01.022","volume":"65","author":"CM Henry","year":"2017","unstructured":"Henry, C. M. & Martin, S. J. Caspase-8 Acts in a Non-enzymatic role as a scaffold for assembly of a pro-inflammatory \u201cFADDosome\u201d complex upon TRAIL stimulation. Mol. Cell 65, 715\u2013729.e5 (2017).","journal-title":"Mol. Cell"},{"key":"1327_CR159","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.immuni.2020.04.010","volume":"52","author":"B Tummers","year":"2020","unstructured":"Tummers, B. et al. Caspase-8-dependent inflammatory responses are controlled by its adaptor, FADD, and Necroptosis. Immunity 52, 994\u20131006.e8 (2020).","journal-title":"Immunity"},{"key":"1327_CR160","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.immuni.2020.04.002","volume":"52","author":"R Schwarzer","year":"2020","unstructured":"Schwarzer, R., Jiao, H., Wachsmuth, L., Tresch, A. & Pasparakis, M. FADD and Caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells. Immunity 52, 978\u2013993.e6 (2020).","journal-title":"Immunity"},{"key":"1327_CR161","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10400","volume":"477","author":"C G\u00fcnther","year":"2011","unstructured":"G\u00fcnther, C. et al. Caspase-8 regulates TNF-\u03b1-induced epithelial necroptosis and terminal ileitis. Nature 477, 335\u2013339 (2011).","journal-title":"Nature"},{"key":"1327_CR162","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.molcel.2017.01.021","volume":"65","author":"T Hartwig","year":"2017","unstructured":"Hartwig, T. et al. The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2. Mol. Cell 65, 730\u2013742.e5 (2017).","journal-title":"Mol. Cell"},{"key":"1327_CR163","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-020-2796-5","volume":"587","author":"AD Gitlin","year":"2020","unstructured":"Gitlin, A. D. et al. Integration of innate immune signalling by caspase-8 cleavage of N4BP1. Nature 587, 275\u2013280 (2020).","journal-title":"Nature"},{"key":"1327_CR164","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368\u2013372 (2011).","journal-title":"Nature"},{"key":"1327_CR165","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.immuni.2016.07.016","volume":"45","author":"S Alvarez-Diaz","year":"2016","unstructured":"Alvarez-Diaz, S. et al. The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis. Immunity 45, 513\u2013526 (2016).","journal-title":"Immunity"},{"key":"1327_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0609.2011.01617.x","volume":"87","author":"M Madkaikar","year":"2011","unstructured":"Madkaikar, M., Mhatre, S., Gupta, M. & Ghosh, K. Advances in autoimmune lymphoproliferative syndromes. Eur. J. Haematol. 87, 1\u20139 (2011).","journal-title":"Eur. J. Haematol."},{"key":"1327_CR167","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","volume":"148","author":"DT Teachey","year":"2010","unstructured":"Teachey, D. T., Seif, A. E. & Grupp, S. A. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br. J. Haematol. 148, 205\u2013216 (2010).","journal-title":"Br. J. Haematol."},{"key":"1327_CR168","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1056\/NEJMp048116","volume":"351","author":"JM Puck","year":"2004","unstructured":"Puck, J. M. & Straus, S. E. Somatic mutations \u2014 not just for cancer anymore. N. Engl. J. Med. 351, 1388\u20131390 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1327_CR169","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ajhg.2010.10.028","volume":"87","author":"A Bolze","year":"2010","unstructured":"Bolze, A. et al. Whole-exome-sequencing-based discovery of human FADD deficiency. Am. J. Hum. Genet. 87, 873\u2013881 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"1327_CR170","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jaci.2015.02.002","volume":"136","author":"S Savic","year":"2015","unstructured":"Savic, S. et al. A new case of Fas-associated death domain protein deficiency and update on treatment outcomes. J. Allergy Clin. Immunol. 136, 502\u2013505.e4 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR171","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s10875-020-00779-6","volume":"40","author":"LA Kohn","year":"2020","unstructured":"Kohn, L. A., Long, J. D., Trope, E. C. & Kuo, C. Y. Novel compound heterozygote variations in FADD identified to cause FAS-associated protein with death domain deficiency. J. Clin. Immunol. 40, 658\u2013661 (2020).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR172","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1111\/epi.18008","volume":"65","author":"G Giovannini","year":"2024","unstructured":"Giovannini, G. et al. FADD gene pathogenic variants causing recurrent febrile infection-related epilepsy syndrome: case report and literature review. Epilepsia 65, e119\u2013e124 (2024).","journal-title":"Epilepsia"},{"key":"1327_CR173","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/32681","volume":"392","author":"J Zhang","year":"1998","unstructured":"Zhang, J., Cado, D., Chen, A., Kabra, N. H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD\/Mort1. Nature 392, 296\u2013300 (1998).","journal-title":"Nature"},{"key":"1327_CR174","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1126\/science.279.5358.1954","volume":"279","author":"W-C Yeh","year":"1998","unstructured":"Yeh, W.-C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954\u20131958 (1998).","journal-title":"Science"},{"key":"1327_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1006730112726","volume":"21","author":"H-C Hsu","year":"2001","unstructured":"Hsu, H.-C., Matsuki, Y., Zhang, H.-G., Zhou, T. & Mountz, J. D. The Fas signaling connection between autoimmunity and embryonic lethality. J. Clin. Immunol. 21, 1\u201314 (2001).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR176","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1016\/j.celrep.2016.06.103","volume":"16","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. MLKL and FADD are critical for suppressing progressive lymphoproliferative disease and activating the NLRP3 inflammasome. Cell Rep. 16, 3247\u20133259 (2016).","journal-title":"Cell Rep."},{"key":"1327_CR177","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/emboj\/19.5.931","volume":"19","author":"K Newton","year":"2000","unstructured":"Newton, K., Harris, A. W. & Strasser, A. FADD\/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19, 931\u2013941 (2000).","journal-title":"EMBO J."},{"key":"1327_CR178","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/emboj\/17.3.706","volume":"17","author":"K Newton","year":"1998","unstructured":"Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. C. & Strasser, A. A dominant interfering mutant of FADD\/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706\u2013718 (1998).","journal-title":"EMBO J."},{"key":"1327_CR179","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.4049\/jimmunol.175.5.3033","volume":"175","author":"Y Zhang","year":"2005","unstructured":"Zhang, Y. et al. Conditional Fas-associated death domain protein (FADD):GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J. Immunol. 175, 3033\u20133044 (2005).","journal-title":"J. Immunol."},{"key":"1327_CR180","doi-asserted-by":"publisher","first-page":"13034","DOI":"10.1073\/pnas.1005997107","volume":"107","author":"SL Osborn","year":"2010","unstructured":"Osborn, S. L. et al. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc. Natl Acad. Sci. 107, 13034\u201313039 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR181","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.111158698","volume":"98","author":"NH Kabra","year":"2001","unstructured":"Kabra, N. H., Kang, C., Hsing, L. C., Zhang, J. & Winoto, A. T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc. Natl Acad. Sci. USA 98, 6307\u20136312 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1327_CR182","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1074-7613(00)80549-X","volume":"8","author":"CM Walsh","year":"1998","unstructured":"Walsh, C. M. et al. A role for FADD in T cell activation and development. Immunity 8, 439\u2013449 (1998).","journal-title":"Immunity"},{"key":"1327_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.251","volume":"7","author":"C Fan","year":"2016","unstructured":"Fan, C. et al. Lack of FADD in Tie-2 expressing cells causes RIPK3-mediated embryonic lethality. Cell Death Dis. 7, e2351 (2016).","journal-title":"Cell Death Dis."},{"key":"1327_CR184","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature03124","volume":"432","author":"S Balachandran","year":"2004","unstructured":"Balachandran, S., Thomas, E. & Barber, G. N. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432, 401\u2013405 (2004).","journal-title":"Nature"},{"key":"1327_CR185","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.4049\/jimmunol.178.4.2429","volume":"178","author":"S Balachandran","year":"2007","unstructured":"Balachandran, S., Venkataraman, T., Fisher, P. B. & Barber, G. N. Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J. Immunol. 178, 2429\u20132439 (2007).","journal-title":"J. Immunol."},{"key":"1327_CR186","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcdb.2020.07.001","volume":"109","author":"Y Topal","year":"2021","unstructured":"Topal, Y. & Gyrd-Hansen, M. RIPK2 NODs to XIAP and IBD. Semin. Cell Dev. Biol. 109, 144\u2013150 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1327_CR187","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jaci.2014.04.031","volume":"134","author":"C Aguilar","year":"2014","unstructured":"Aguilar, C. et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J. Allergy Clin. Immunol. 134, 1131\u20131141.e9 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR188","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10875-011-9638-z","volume":"32","author":"X Yang","year":"2012","unstructured":"Yang, X. et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J. Clin. Immunol. 32, 411\u2013420 (2012).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR189","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10875-015-0166-0","volume":"35","author":"M Dziadzio","year":"2015","unstructured":"Dziadzio, M. et al. Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. J. Clin. Immunol. 35, 439\u2013444 (2015).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR190","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud, S. et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444, 110\u2013114 (2006).","journal-title":"Nature"},{"key":"1327_CR191","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semcdb.2015.01.015","volume":"39","author":"S Latour","year":"2015","unstructured":"Latour, S. & Aguilar, C. XIAP deficiency syndrome in humans. Semin. Cell Dev. Biol. 39, 115\u2013123 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1327_CR192","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","volume":"117","author":"JP Schmid","year":"2011","unstructured":"Schmid, J. P. et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency). Blood 117, 1522\u20131529 (2011).","journal-title":"Blood"},{"key":"1327_CR193","doi-asserted-by":"publisher","first-page":"660520","DOI":"10.3389\/fped.2021.660520","volume":"9","author":"ACA Mudde","year":"2021","unstructured":"Mudde, A. C. A., Booth, C. & Marsh, R. A. Evolution of our understanding of XIAP deficiency. Front. Pediatr. 9, 660520 (2021).","journal-title":"Front. Pediatr."},{"key":"1327_CR194","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/gutjnl-2013-306520","volume":"64","author":"Y Zeissig","year":"2015","unstructured":"Zeissig, Y. et al. XIAP variants in male Crohn\u2019s disease. Gut 64, 66\u201376 (2015).","journal-title":"Gut"},{"key":"1327_CR195","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1136\/gutjnl-2013-306474","volume":"63","author":"C Speckmann","year":"2014","unstructured":"Speckmann, C. & Ehl, S. XIAP deficiency is a mendelian cause of late-onset IBD. Gut 63, 1031\u20131032 (2014).","journal-title":"Gut"},{"key":"1327_CR196","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2010.11.040","volume":"127","author":"PC Horn","year":"2011","unstructured":"Horn, P. C. et al. Two new families with X-linked inhibitor of apoptosis deficiency and a review of all 26 published cases. J. Allergy Clin. Immunol. 127, 544\u2013546 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR197","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/emmm.201303090","volume":"5","author":"RB Damgaard","year":"2013","unstructured":"Damgaard, R. B. et al. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. EMBO Mol. Med. 5, 1278\u20131295 (2013).","journal-title":"EMBO Mol. Med."},{"key":"1327_CR198","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2014-03-564609","volume":"124","author":"W-C Hsieh","year":"2014","unstructured":"Hsieh, W.-C. et al. Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap\u2212\/\u2212 mice. Blood 124, 2847\u20132857 (2014).","journal-title":"Blood"},{"key":"1327_CR199","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7235","volume":"6","author":"A Wahida","year":"2021","unstructured":"Wahida, A. et al. XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells. Sci. Immunol. 6, eabf7235 (2021).","journal-title":"Sci. Immunol."},{"key":"1327_CR200","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7473","volume":"6","author":"A Strigli","year":"2021","unstructured":"Strigli, A. et al. Deficiency in X-linked inhibitor of apoptosis protein promotes susceptibility to microbial triggers of intestinal inflammation. Sci. Immunol. 6, eabf7473 (2021).","journal-title":"Sci. Immunol."},{"key":"1327_CR201","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1182\/blood.2023023707","volume":"144","author":"D Dissanayake","year":"2024","unstructured":"Dissanayake, D. et al. Interleukin-1-mediated hyperinflammation in XIAP deficiency is associated with defective autophagy. Blood 144, 1183\u20131192 (2024).","journal-title":"Blood"},{"key":"1327_CR202","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2016","unstructured":"Zhou, Q. et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat. Genet. 48, 67\u201373 (2016).","journal-title":"Nat. Genet."},{"key":"1327_CR203","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.alit.2016.06.006","volume":"66","author":"H Ohnishi","year":"2017","unstructured":"Ohnishi, H., Kawamoto, N., Seishima, M., Ohara, O. & Fukao, T. A Japanese family case with juvenile onset Beh\u00e7et\u2019s disease caused by TNFAIP3 mutation. Allergol. Int. 66, 146\u2013148 (2017).","journal-title":"Allergol. Int."},{"key":"1327_CR204","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000223","volume":"2","author":"T Shigemura","year":"2016","unstructured":"Shigemura, T. et al. Novel heterozygous C243Y A20\/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Beh\u00e7et\u2019s disease. RMD Open. 2, e000223 (2016).","journal-title":"RMD Open."},{"key":"1327_CR205","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jid.2023.12.007","volume":"144","author":"I Elhani","year":"2024","unstructured":"Elhani, I. et al. A20 Haploinsufficiency: a systematic review of 177 cases. J. Investig. Dermatol. 144, 1282\u20131294.e8 (2024).","journal-title":"J. Investig. Dermatol."},{"key":"1327_CR206","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13075-019-1928-5","volume":"21","author":"N Tsuchida","year":"2019","unstructured":"Tsuchida, N. et al. Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Beh\u00e7et\u2019s disease. Arthritis Res. Ther. 21, 137 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"1327_CR207","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10875-020-00823-5","volume":"40","author":"MD Gans","year":"2020","unstructured":"Gans, M. D., Wang, H., Moura, N. S., Aksentijevich, I. & Rubinstein, A. A20 Haploinsufficiency presenting with a combined immunodeficiency. J. Clin. Immunol. 40, 1041\u20131044 (2020).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR208","doi-asserted-by":"publisher","first-page":"1548042","DOI":"10.3389\/fimmu.2025.1548042","volume":"16","author":"M Shiraki","year":"2025","unstructured":"Shiraki, M. et al. Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey. Front. Immunol. 16, 1548042 (2025).","journal-title":"Front. Immunol."},{"key":"1327_CR209","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10875-024-01681-1","volume":"44","author":"U Karri","year":"2024","unstructured":"Karri, U., Harasimowicz, M., Tumba, M. C. & Schwartz, D. M. The complexity of being A20: from biological functions to genetic associations. J. Clin. Immunol. 44, 76 (2024).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR210","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-4939-0398-6_10","volume":"809","author":"A Mele","year":"2014","unstructured":"Mele, A., Cervantes, J. R., Chien, V., Friedman, D. & Ferran, C. The multiple therapeutic targets of A20. Adv. Exp. Med. Biol. 809, 163\u2013183 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1327_CR211","doi-asserted-by":"publisher","first-page":"a036418","DOI":"10.1101\/cshperspect.a036418","volume":"12","author":"A Martens","year":"2019","unstructured":"Martens, A. & van Loo, G. A20 at the crossroads of cell death, inflammation, and autoimmunity. Cold Spring Harb. Perspect. Biol. 12, a036418 (2019).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1327_CR212","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.immuni.2013.03.008","volume":"38","author":"TT Lu","year":"2013","unstructured":"Lu, T. T. et al. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity 38, 896\u2013905 (2013).","journal-title":"Immunity"},{"key":"1327_CR213","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41590-020-0634-4","volume":"21","author":"B Razani","year":"2020","unstructured":"Razani, B. et al. Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis\u2013like disease and inflammation. Nat. Immunol. 21, 422\u2013433 (2020).","journal-title":"Nat. Immunol."},{"key":"1327_CR214","doi-asserted-by":"publisher","first-page":"775","DOI":"10.15252\/embr.201338305","volume":"15","author":"A De","year":"2014","unstructured":"De, A., Dainichi, T., Rathinam, C. V. & Ghosh, S. The deubiquitinase activity of A20 is dispensable for NF-\u03baB signaling. EMBO Rep. 15, 775\u2013783 (2014).","journal-title":"EMBO Rep."},{"key":"1327_CR215","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature16165","volume":"528","author":"IE Wertz","year":"2015","unstructured":"Wertz, I. E. et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528, 370\u2013375 (2015).","journal-title":"Nature"},{"key":"1327_CR216","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41556-019-0324-3","volume":"21","author":"A Polykratis","year":"2019","unstructured":"Polykratis, A. et al. A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain. Nat. Cell Biol. 21, 731\u2013742 (2019).","journal-title":"Nat. Cell Biol."},{"key":"1327_CR217","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41590-020-0621-9","volume":"21","author":"A Martens","year":"2020","unstructured":"Martens, A. et al. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities. Nat. Immunol. 21, 381\u2013387 (2020).","journal-title":"Nat. Immunol."},{"key":"1327_CR218","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"EG Lee","year":"2000","unstructured":"Lee, E. G. et al. Failure to regulate TNF-induced NF-\u03baB and cell death responses in A20-deficient mice. Science 289, 2350\u20132354 (2000).","journal-title":"Science"},{"key":"1327_CR219","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/ni1110","volume":"5","author":"DL Boone","year":"2004","unstructured":"Boone, D. L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052\u20131060 (2004).","journal-title":"Nat. Immunol."},{"key":"1327_CR220","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1084\/jem.20071108","volume":"205","author":"EE Turer","year":"2008","unstructured":"Turer, E. E. et al. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J. Exp. Med. 205, 451\u2013464 (2008).","journal-title":"J. Exp. Med."},{"key":"1327_CR221","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.3172","volume":"16","author":"M Onizawa","year":"2015","unstructured":"Onizawa, M. et al. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat. Immunol. 16, 618\u2013627 (2015).","journal-title":"Nat. Immunol."},{"key":"1327_CR222","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/cdd.2016.46","volume":"23","author":"K Newton","year":"2016","unstructured":"Newton, K. et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23, 1565\u20131576 (2016).","journal-title":"Cell Death Differ."},{"key":"1327_CR223","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ng.874","volume":"43","author":"M Matmati","year":"2011","unstructured":"Matmati, M. et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat. Genet. 43, 908\u2013912 (2011).","journal-title":"Nat. Genet."},{"key":"1327_CR224","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature13322","volume":"512","author":"LV Walle","year":"2014","unstructured":"Walle, L. V. et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 512, 69\u201373 (2014).","journal-title":"Nature"},{"key":"1327_CR225","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180481","volume":"12","author":"A Aki","year":"2017","unstructured":"Aki, A., Nagasaki, M., Malynn, B. A., Ma, A. & Kagari, T. Hypomorphic A20 expression confers susceptibility to psoriasis. PLoS ONE 12, e0180481 (2017).","journal-title":"PLoS ONE"},{"key":"1327_CR226","doi-asserted-by":"publisher","first-page":"18601","DOI":"10.1073\/pnas.0709011104","volume":"104","author":"S Wolfrum","year":"2007","unstructured":"Wolfrum, S., Teupser, D., Tan, M., Chen, K. Y. & Breslow, J. L. The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-\u03baB target genes. Proc. Natl Acad. Sci. 104, 18601\u201318606 (2007).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR227","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2010.07.017","volume":"33","author":"RM Tavares","year":"2010","unstructured":"Tavares, R. M. et al. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33, 181\u2013191 (2010).","journal-title":"Immunity"},{"key":"1327_CR228","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.immuni.2024.11.023","volume":"58","author":"C Diehl","year":"2025","unstructured":"Diehl, C. et al. Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis. Immunity 58, 124\u2013142.e15 (2025).","journal-title":"Immunity"},{"key":"1327_CR229","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl3975","volume":"10","author":"C Schulthei\u00df","year":"2024","unstructured":"Schulthei\u00df, C. et al. A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors. Sci. Adv. 10, eadl3975 (2024).","journal-title":"Sci. Adv."},{"key":"1327_CR230","doi-asserted-by":"publisher","first-page":"780689","DOI":"10.3389\/fimmu.2021.780689","volume":"12","author":"T Kadowaki","year":"2021","unstructured":"Kadowaki, T., Kadowaki, S. & Ohnishi, H. A20 haploinsufficiency in East Asia. Front. Immunol. 12, 780689 (2021).","journal-title":"Front. Immunol."},{"key":"1327_CR231","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/annrheumdis-2016-210944","volume":"77","author":"CJA Duncan","year":"2018","unstructured":"Duncan, C. J. A. et al. Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20). Ann. Rheum. Dis. 77, 783\u2013786 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR232","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1007\/s10875-021-01124-1","volume":"41","author":"M Shiraki","year":"2021","unstructured":"Shiraki, M. et al. Hematopoietic cell transplantation ameliorates autoinflammation in A20 haploinsufficiency. J. Clin. Immunol. 41, 1954\u20131956 (2021).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR233","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s10875-021-01048-w","volume":"41","author":"CW Wu","year":"2021","unstructured":"Wu, C. W. et al. Complicated diagnosis and treatment of HA20 due to contiguous gene deletions involving 6q23.3. J. Clin. Immunol. 41, 1420\u20131423 (2021).","journal-title":"J. Clin. Immunol."},{"key":"1327_CR234","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/annrheumdis-2019-215918","volume":"79","author":"DM Schwartz","year":"2019","unstructured":"Schwartz, D. M. et al. Type I interferon signature predicts response to JAK inhibition in haploinsufficiency of A20. Ann. Rheum. Dis. 79, 429\u2013431 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1327_CR235","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaci.2019.05.026","volume":"144","author":"CM Mulhern","year":"2019","unstructured":"Mulhern, C. M. et al. Janus kinase 1\/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation. J. Allergy Clin. Immunol. 144, 863\u2013866.e5 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR236","doi-asserted-by":"publisher","first-page":"R506","DOI":"10.1016\/j.cub.2022.04.041","volume":"32","author":"Y Shibata","year":"2022","unstructured":"Shibata, Y. & Komander, D. LUBAC. Curr. Biol. 32, R506\u2013R508 (2022).","journal-title":"Curr. Biol."},{"key":"1327_CR237","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.20141130","volume":"212","author":"B Boisson","year":"2015","unstructured":"Boisson, B. et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J. Exp. Med. 212, 939\u2013951 (2015).","journal-title":"J. Exp. Med."},{"key":"1327_CR238","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/ni.2457","volume":"13","author":"B Boisson","year":"2012","unstructured":"Boisson, B. et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13, 1178\u20131186 (2012).","journal-title":"Nat. Immunol."},{"key":"1327_CR239","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fimmu.2019.00479","volume":"10","author":"H Oda","year":"2019","unstructured":"Oda, H. et al. Second case of HOIP deficiency expands clinical features and defines inflammatory transcriptome regulated by LUBAC. Front. Immunol. 10, 479 (2019).","journal-title":"Front. Immunol."},{"key":"1327_CR240","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.celrep.2014.08.066","volume":"9","author":"N Peltzer","year":"2014","unstructured":"Peltzer, N. et al. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 9, 153\u2013165 (2014).","journal-title":"Cell Rep."},{"key":"1327_CR241","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature09815","volume":"471","author":"F Tokunaga","year":"2011","unstructured":"Tokunaga, F. et al. SHARPIN is a component of the NF-\u03baB-activating linear ubiquitin chain assembly complex. Nature 471, 633\u2013636 (2011).","journal-title":"Nature"},{"key":"1327_CR242","doi-asserted-by":"publisher","first-page":"13293","DOI":"10.1073\/pnas.1905873116","volume":"116","author":"IR Kelsall","year":"2019","unstructured":"Kelsall, I. R., Zhang, J., Knebel, A., Arthur, J. S. C. & Cohen, P. The E3 ligase HOIL-1 catalyses ester bond formation between ubiquitin and components of the Myddosome in mammalian cells. Proc. Natl Acad. Sci. 116, 13293\u201313298 (2019).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR243","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41590-024-01817-w","volume":"25","author":"H Oda","year":"2024","unstructured":"Oda, H. et al. Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency. Nat. Immunol. 25, 764\u2013777 (2024).","journal-title":"Nat. Immunol."},{"key":"1327_CR244","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03422","volume":"3","author":"S Kumari","year":"2014","unstructured":"Kumari, S. et al. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. eLife 3, e03422 (2014).","journal-title":"eLife"},{"key":"1327_CR245","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03464","volume":"3","author":"JA Rickard","year":"2014","unstructured":"Rickard, J. A. et al. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. eLife 3, e03464 (2014).","journal-title":"eLife"},{"key":"1327_CR246","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.4049\/jimmunol.1402951","volume":"194","author":"P Gurung","year":"2015","unstructured":"Gurung, P., Lamkanfi, M. & Kanneganti, T.-D. Cutting edge: SHARPIN is required for optimal NLRP3 inflammasome activation. J. Immunol. 194, 2064\u20132067 (2015).","journal-title":"J. Immunol."},{"key":"1327_CR247","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1084\/jem.20132486","volume":"211","author":"MA Rodgers","year":"2014","unstructured":"Rodgers, M. A. et al. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J. Exp. Med. 211, 1333\u20131347 (2014).","journal-title":"J. Exp. Med."},{"key":"1327_CR248","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13353","volume":"7","author":"CE Teh","year":"2016","unstructured":"Teh, C. E. et al. Linear ubiquitin chain assembly complex coordinates late thymic T-cell differentiation and regulatory T-cell homeostasis. Nat. Commun. 7, 13353 (2016).","journal-title":"Nat. Commun."},{"key":"1327_CR249","first-page":"972","volume":"143","author":"H HogenEsch","year":"1993","unstructured":"HogenEsch, H. et al. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am. J. Pathol. 143, 972\u2013982 (1993).","journal-title":"Am. J. Pathol."},{"key":"1327_CR250","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ni.3352","volume":"17","author":"Y Park","year":"2016","unstructured":"Park, Y. et al. SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex. Nat. Immunol. 17, 286\u2013296 (2016).","journal-title":"Nat. Immunol."},{"key":"1327_CR251","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235295","volume":"15","author":"JP Sundberg","year":"2020","unstructured":"Sundberg, J. P. et al. Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice. PLoS ONE 15, e0235295 (2020).","journal-title":"PLoS ONE"},{"key":"1327_CR252","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/35013114","volume":"405","author":"A Smahi","year":"2000","unstructured":"Smahi, A. et al. Genomic rearrangement in NEMO impairs NF-\u03baB activation and is a cause of incontinentia pigmenti. Nature 405, 466\u2013472 (2000).","journal-title":"Nature"},{"key":"1327_CR253","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/hmg\/ddh192","volume":"13","author":"F Fusco","year":"2004","unstructured":"Fusco, F. et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-\u03baB activation. Hum. Mol. Genet. 13, 1763\u20131773 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"1327_CR254","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/humu.22483","volume":"35","author":"MI Conte","year":"2014","unstructured":"Conte, M. I. et al. Insight into IKBKG\/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease. Hum. Mutat. 35, 165\u2013177 (2014).","journal-title":"Hum. Mutat."},{"key":"1327_CR255","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-93","volume":"9","author":"F Fusco","year":"2014","unstructured":"Fusco, F. et al. Incontinentia pigmenti: report on data from 2000 to 2013. Orphanet J. Rare Dis. 9, 93 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"1327_CR256","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1086\/324591","volume":"69","author":"S Kenwrick","year":"2001","unstructured":"Kenwrick, S. et al. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am. J. Hum. Genet. 69, 1210\u20131217 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"1327_CR257","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/ijms23031179","volume":"23","author":"A Pescatore","year":"2022","unstructured":"Pescatore, A. et al. Human genetic diseases linked to the absence of NEMO: an obligatory somatic mosaic disorder in male. Int. J. Mol. Sci. 23, 1179 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1327_CR258","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/hmg\/10.19.2171","volume":"10","author":"S Aradhya","year":"2001","unstructured":"Aradhya, S. et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK-\u03b3) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum. Mol. Genet. 10, 2171\u20132179 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"1327_CR259","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S1097-2765(00)80262-2","volume":"5","author":"C Makris","year":"2000","unstructured":"Makris, C. et al. Female mice heterozygous for IKK\u03b3\/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5, 969\u2013979 (2000).","journal-title":"Mol. Cell"},{"key":"1327_CR260","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1097-2765(00)80263-4","volume":"5","author":"M Schmidt-Supprian","year":"2000","unstructured":"Schmidt-Supprian, M. et al. NEMO\/IKK\u03b3-deficient mice model incontinentia pigmenti. Mol. Cell 5, 981\u2013992 (2000).","journal-title":"Mol. Cell"},{"key":"1327_CR261","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/hmg\/ddi470","volume":"15","author":"A Nenci","year":"2006","unstructured":"Nenci, A. et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum. Mol. Genet. 15, 531\u2013542 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"1327_CR262","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1172\/JCI124011","volume":"129","author":"B Boisson","year":"2019","unstructured":"Boisson, B. et al. Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency. J. Clin. Investig. 129, 583\u2013597 (2019).","journal-title":"J. Clin. Investig."},{"key":"1327_CR263","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaci.2004.06.052","volume":"114","author":"JS Orange","year":"2004","unstructured":"Orange, J. S. et al. Human nuclear factor \u03baB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J. Allergy Clin. Immunol. 114, 650\u2013656 (2004).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR264","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/85837","volume":"27","author":"R D\u00f6ffinger","year":"2001","unstructured":"D\u00f6ffinger, R. et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-\u03baB signaling. Nat. Genet. 27, 277\u2013285 (2001).","journal-title":"Nat. Genet."},{"key":"1327_CR265","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1172\/JCI18714","volume":"112","author":"G Courtois","year":"2003","unstructured":"Courtois, G. et al. A hypermorphic I\u03baB\u03b1 mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J. Clin. Investig. 112, 1108\u20131115 (2003).","journal-title":"J. Clin. Investig."},{"key":"1327_CR266","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jaci.2017.05.030","volume":"141","author":"D Petersheim","year":"2018","unstructured":"Petersheim, D. et al. Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency. J. Allergy Clin. Immunol. 141, 1060\u20131073.e3 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR267","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jaci.2013.05.034","volume":"132","author":"G Giancane","year":"2013","unstructured":"Giancane, G. et al. Anhidrotic ectodermal dysplasia: a new mutation. J. Allergy Clin. Immunol. 132, 1451\u20131453 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR268","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/humu.20740","volume":"29","author":"E Lopez-Granados","year":"2008","unstructured":"Lopez-Granados, E. et al. A novel mutation in NFKBIA\/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum. Mutat. 29, 861\u2013868 (2008).","journal-title":"Hum. Mutat."},{"key":"1327_CR269","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/316914","volume":"67","author":"J Zonana","year":"2000","unstructured":"Zonana, J. et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet. 67, 1555\u20131562 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"1327_CR270","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1084\/jem.20040773","volume":"200","author":"R Janssen","year":"2004","unstructured":"Janssen, R. et al. The same I\u03baB\u03b1 mutation in two related individuals leads to completely different clinical syndromes. J. Exp. Med. 200, 559\u2013568 (2004).","journal-title":"J. Exp. Med."},{"key":"1327_CR271","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jaci.2007.08.035","volume":"120","author":"DR McDonald","year":"2007","unstructured":"McDonald, D. R. et al. Heterozygous N-terminal deletion of I\u03baB\u03b1 results in functional nuclear factor \u03baB haploinsufficiency, ectodermal dysplasia, and immune deficiency. J. Allergy Clin. Immunol. 120, 900\u2013907 (2007).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR272","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jaci.2011.09.042","volume":"129","author":"H Ohnishi","year":"2012","unstructured":"Ohnishi, H. et al. A rapid screening method to detect autosomal-dominant ectodermal dysplasia with immune deficiency syndrome. J. Allergy Clin. Immunol. 129, 578\u2013580 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR273","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jaci.2007.12.337","volume":"121","author":"EP Hanson","year":"2008","unstructured":"Hanson, E. P. & Orange, J. S. NEMO genotype-phenotype correlations drawn from a database analysis. J. Allergy Clin. Immunol. 121, S84 (2008).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR274","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1182\/blood-2017-03-771600","volume":"130","author":"C Miot","year":"2017","unstructured":"Miot, C. et al. Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG\/NEMO mutations. Blood 130, 1456\u20131467 (2017).","journal-title":"Blood"},{"key":"1327_CR275","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature05698","volume":"446","author":"A Nenci","year":"2007","unstructured":"Nenci, A. et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557\u2013561 (2007).","journal-title":"Nature"},{"key":"1327_CR276","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.immuni.2016.02.020","volume":"44","author":"K Vlantis","year":"2016","unstructured":"Vlantis, K. et al. NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-\u03baB-dependent and -independent functions. Immunity 44, 553\u2013567 (2016).","journal-title":"Immunity"},{"key":"1327_CR277","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","volume":"27","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases. Cell Death Differ. 27, 161\u2013175 (2020).","journal-title":"Cell Death Differ."},{"key":"1327_CR278","doi-asserted-by":"publisher","DOI":"10.1172\/JCI128808","volume":"132","author":"Y Lee","year":"2022","unstructured":"Lee, Y. et al. Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype. J. Clin. Investig. 132, e128808 (2022).","journal-title":"J. Clin. Investig."},{"key":"1327_CR279","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1097\/DAD.0000000000002144","volume":"44","author":"S Hegazy","year":"2022","unstructured":"Hegazy, S. et al. NEMO-NDAS: a panniculitis in the young representing an autoinflammatory disorder in disguise. Am. J. Dermatopathol. 44, e64\u2013e66 (2022).","journal-title":"Am. J. Dermatopathol."},{"key":"1327_CR280","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1172\/JCI129301","volume":"130","author":"AA Jesus","year":"2019","unstructured":"Jesus, A. A. et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J. Clin. Investig. 130, 1669\u20131682 (2019).","journal-title":"J. Clin. Investig."},{"key":"1327_CR281","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-024-01799-2","volume":"45","author":"J Eigemann","year":"2025","unstructured":"Eigemann, J. et al. Non-skewed X-inactivation results in NF-\u03baB essential modulator (NEMO) \u0394-exon 5-autoinflammatory syndrome (NEMO-NDAS) in a female with incontinentia pigmenti. J. Clin. Immunol. 45, 1 (2025).","journal-title":"J. Clin. Immunol."},{"issue":"abstr","key":"1327_CR282","first-page":"0471","volume":"130","author":"A de Jesus","year":"2020","unstructured":"de Jesus, A. et al. Splice site variants in IKBKG, encoding NEMO, detected by a customized analysis of next-generation sequencing data cause an early-onset autoinflammatory syndrome of panniculitis and cytopenias in male and female patients. Arthritis Rheumatol. 72, abstr. 0471 (2020).","journal-title":"Arthritis Rheumatol."},{"issue":"abstr","key":"1327_CR283","first-page":"1773","volume":"76","author":"AA de Jesus","year":"2024","unstructured":"de Jesus, A. A. et al. Divergent genetic architecture in boys and girls with NEMO-deleted exon 5 autoinflammatory syndrome (NEMO-NDAS) implies role for wildtype effector cells. Arthritis Rheumatol. 76, abstr. 1773 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1327_CR284","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20160724","volume":"214","author":"YR Badran","year":"2017","unstructured":"Badran, Y. R. et al. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J. Exp. Med. 214, 1937\u20131947 (2017).","journal-title":"J. Exp. Med."},{"key":"1327_CR285","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jaci.2017.11.036","volume":"141","author":"WA Comrie","year":"2018","unstructured":"Comrie, W. A. et al. RELA haploinsufficiency in CD4 lymphoproliferative disease with autoimmune cytopenias. J. Allergy Clin. Immunol. 141, 1507\u20131510.e8 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1327_CR286","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/rheumatology\/keac227","volume":"62","author":"K Lecerf","year":"2022","unstructured":"Lecerf, K. et al. Case report and review of the literature: immune dysregulation in a large familial cohort due to a novel pathogenic RELA variant. Rheumatology 62, 347\u2013359 (2022).","journal-title":"Rheumatology"},{"key":"1327_CR287","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212276","volume":"220","author":"K Moriya","year":"2023","unstructured":"Moriya, K. et al. Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity. J. Exp. Med. 220, e20212276 (2023).","journal-title":"J. Exp. Med."},{"key":"1327_CR288","doi-asserted-by":"publisher","first-page":"1529654","DOI":"10.3389\/fimmu.2025.1529654","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Case report and literature review: clinical manifestations and treatment of human RelA deficiency. Front. Immunol. 16, 1529654 (2025).","journal-title":"Front. Immunol."},{"key":"1327_CR289","doi-asserted-by":"publisher","unstructured":"Barnabei, L. et al. Heterozygous RELA mutations cause early-onset systemic lupus erythematosus by hijacking the NF-\u03baB pathway towards transcriptional activation of type-I Interferon genes. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.04.27.046102 (2020).","DOI":"10.1101\/2020.04.27.046102"},{"key":"1327_CR290","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.immuni.2024.04.025","volume":"57","author":"J Mannion","year":"2024","unstructured":"Mannion, J. et al. A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death. Immunity 57, 1514\u20131532.e15 (2024).","journal-title":"Immunity"},{"key":"1327_CR291","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55006-2","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Development of a RIPK1 degrader to enhance antitumor immunity. Nat. Commun. 15, 10683 (2024).","journal-title":"Nat. Commun."},{"key":"1327_CR292","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","volume":"18","author":"A Freischmidt","year":"2015","unstructured":"Freischmidt, A. et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631\u2013636 (2015).","journal-title":"Nat. Neurosci."},{"key":"1327_CR293","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli, E. T. et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436\u20131441 (2015).","journal-title":"Science"},{"key":"1327_CR294","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00401-015-1436-x","volume":"130","author":"C Pottier","year":"2015","unstructured":"Pottier, C. et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 130, 77\u201392 (2015).","journal-title":"Acta Neuropathol."},{"key":"1327_CR295","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan, J., Amin, P. & Ofengeim, D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat. Rev. Neurosci. 20, 19\u201333 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"1327_CR296","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/cts.13317","volume":"15","author":"MFJM Vissers","year":"2022","unstructured":"Vissers, M. F. J. M. et al. Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients. Clin. Transl. Sci. 15, 2010\u20132023 (2022).","journal-title":"Clin. Transl. Sci."},{"key":"1327_CR297","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tibs.2024.11.006","volume":"50","author":"H Hoblos","year":"2025","unstructured":"Hoblos, H., Cawthorne, W., Samson, A. L. & Murphy, J. M. Protein shapeshifting in necroptotic cell death signaling. Trends Biochem. Sci. 50, 92\u2013105 (2025).","journal-title":"Trends Biochem. Sci."},{"key":"1327_CR298","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","volume":"56","author":"P Mandal","year":"2014","unstructured":"Mandal, P. et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56, 481\u2013495 (2014).","journal-title":"Mol. Cell"},{"key":"1327_CR299","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1126\/science.1249361","volume":"343","author":"K Newton","year":"2014","unstructured":"Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357\u20131360 (2014).","journal-title":"Science"},{"key":"1327_CR300","doi-asserted-by":"publisher","first-page":"eade2860","DOI":"10.1126\/sciimmunol.ade2860","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Encephalitis and poor neuronal death-mediated control of herpes simplex virus in human inherited RIPK3 deficiency. Sci. Immunol. 8, eade2860 (2023).","journal-title":"Sci. Immunol."},{"key":"1327_CR301","doi-asserted-by":"publisher","first-page":"15438","DOI":"10.1073\/pnas.1412767111","volume":"111","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Direct activation of RIP3\/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc. Natl Acad. Sci. 111, 15438\u201315443 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1327_CR302","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2016.05.011","volume":"20","author":"S Nogusa","year":"2016","unstructured":"Nogusa, S. et al. RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus. Cell Host Microbe 20, 13\u201324 (2016).","journal-title":"Cell Host Microbe"},{"key":"1327_CR303","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cell.2017.03.011","volume":"169","author":"BP Daniels","year":"2017","unstructured":"Daniels, B. P. et al. RIPK3 restricts viral pathogenesis via cell death-independent neuroinflammation. Cell 169, 301\u2013313.e11 (2017).","journal-title":"Cell"},{"key":"1327_CR304","doi-asserted-by":"publisher","first-page":"637710","DOI":"10.3389\/fcimb.2021.637710","volume":"11","author":"C Wen","year":"2021","unstructured":"Wen, C. et al. RIPK3-dependent necroptosis is induced and restricts viral replication in human astrocytes infected with zika virus. Front. Cell. Infect. Microbiol. 11, 637710 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1327_CR305","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.immuni.2018.11.017","volume":"50","author":"BP Daniels","year":"2019","unstructured":"Daniels, B. P. et al. The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity 50, 64\u201376.e4 (2019).","journal-title":"Immunity"},{"key":"1327_CR306","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/cdd.2015.169","volume":"23","author":"MC Tanzer","year":"2016","unstructured":"Tanzer, M. C. et al. Evolutionary divergence of the necroptosis effector MLKL. Cell Death Differ. 23, 1185\u20131197 (2016).","journal-title":"Cell Death Differ."},{"key":"1327_CR307","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41418-018-0061-3","volume":"25","author":"KA Davies","year":"2018","unstructured":"Davies, K. A. et al. The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis. Cell Death Differ. 25, 1567\u20131580 (2018).","journal-title":"Cell Death Differ."},{"key":"1327_CR308","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04714-7","volume":"9","author":"EJ Petrie","year":"2018","unstructured":"Petrie, E. J. et al. Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis. Nat. Commun. 9, 2422 (2018).","journal-title":"Nat. Commun."},{"key":"1327_CR309","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0939-8600(00)80001-2","volume":"41","author":"JP Sundberg","year":"2000","unstructured":"Sundberg, J. P. et al. The chronic proliferative dermatitis mouse mutation (cpdm): mapping of the mutant gene locus. J. Exp. Anim. Sci. 41, 101\u2013108 (2000).","journal-title":"J. Exp. Anim. Sci."},{"key":"1327_CR310","doi-asserted-by":"publisher","unstructured":"Zammit, N. W. et al. Environmental and genetic disease modifiers of haploinsufficiency of A20. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.03.19.485004 (2022).","DOI":"10.1101\/2022.03.19.485004"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01327-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T01:01:47Z","timestamp":1766365307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01327-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":310,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01327-5","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"4 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}